Depuy Ireland Unlimited Company
USPTO PatentsView assignee record - 420 granted patents across 34 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Depuy ranks #1,038 of 49,997 tracked US assignees by granted-patent volume, with 420 patents across 34 technology areas.
- #1,038
- of 49,997 US assignees by volume
- Top 4%
- by Innovation Score (59.8/100)
- 13.3
- avg claims per patent
- -2%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R1038 · Foreign Corporation #1,038 · 420 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
- GRANTS-MID 420 grants
- TOP-DECILE #1,038/49,997
- PHOTO-FINISH Scania CV AB
- CPC-FOCUS A61F · 34 areas
- INNOV-PAR 59.8/100
- CLAIMS-RICH 13.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-FLAT -2% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Scania CV AB (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Depuy’s 59.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Depuy
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Sunpower · near
Sunpower · near
60 score
- CCS Technology · near
CCS Technology · near
60 score
- Depuy Ireland… · this assignee
Depuy Ireland… · this assignee
60 score
- Shanghai Harvest… · near
Shanghai Harvest… · near
60 score
- Transform SR Brands · near
Transform SR Brands · near
60 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Depuy's Innovation Score is 59.8/100 (top 4% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Depuy?
Each dot is one of Depuy’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Depuy’s own 13.3 claims/patent is at or below the 16.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Depuy's grants concentrate
Depuy Ireland Unlimited Company is a focused PatentsView assignee: 34 CPC subclasses with 71.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2015 (64 grants) versus a trough of 22 in 2021. By volume, Depuy sits between Fu Tai Hua Industry (Shenzhen) Co., Ltd. and KHS GmbH.
Depuy's three-year grant acceleration
From 2019–2021 to 2022–2024, Depuy Ireland Unlimited Company moved from 89 to 138 grants (1.55x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #409. See the growth leaderboard.
Who files at Depuy's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Fu Tai Hua Indust…
Fu Tai Hua Industry (Shenzhen) Co., Ltd.
422 patents
- Advics
Advics Co., Ltd.
421 patents
- GN Hearing A/S
GN Hearing A/S
421 patents
- Worldpay
Worldpay, LLC
421 patents
- Scania CV AB
Scania CV AB
420 patents
- Depuy Ireland Unl… ◀
Depuy Ireland Unlimited Company
420 patents
- Varian Medical Sy…
Varian Medical Systems, Inc.
419 patents
- Postech Academy-i…
Postech Academy-industry Foundation
418 patents
- KHS
KHS GmbH
417 patents
What this shows Depuy holds 420 patents at rank #1,038, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Depuy
By rank, the assignees closest to #1,038 in granted patent volume.
- Fu Tai Hua Industry (Shenzhen) Co., Ltd. #1,034 · 422 patents
- Advics Co., Ltd. #1,035 · 421 patents
- GN Hearing A/S #1,036 · 421 patents
- Worldpay, LLC #1,037 · 421 patents
- Scania CV AB #1,039 · 420 patents
- Varian Medical Systems, Inc. #1,040 · 419 patents
- Postech Academy-industry Foundation #1,041 · 418 patents
- KHS GmbH #1,042 · 417 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Depuy's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Depuy, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Depuy ranks #22 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (60 here).
Similar claim depth
Nearest assignees by average claims per patent (13.3 here).
Depuy's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
60 Top 4% higher than 96% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 64 | 15.2% |
| 2016 | 32 | 7.6% |
| 2017 | 28 | 6.7% |
| 2018 | 30 | 7.1% |
| 2019 | 38 | 9.0% |
| 2020 | 29 | 6.9% |
| 2021 | 22 | 5.2% |
| 2022 | 46 | 11.0% |
| 2023 | 40 | 9.5% |
| 2024 | 52 | 12.4% |
| 2025partial year | 39 | 9.3% |
Which technologies does Depuy Ireland Unlimited Company patent most?
Top 15 of 34 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Depuy Ireland Unlimited Company's patent record in context - here's where to go next.
- Depuy Ireland Unlimited Company's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 71.9% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #1,038 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Depuy Ireland Unlimited Company against Fu Tai Hua Industry (Shenzhen) Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 59.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.